#Enzo #Biochem #Announces #Date #Annual #Stockholders #Meeting
NEW YORK, NY, Nov. 08, 2022 (GLOBE NEWSWIRE) — Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading life sciences and diagnostics company, announced today that its Annual Shareholders Meeting will be held on January 31, 2023. Shareholders must submit nominations and/or nominations of directors in connection with the Meeting no later than November 18, 2022 for timely consideration.
Enzo Biochem is a pioneer in molecular diagnostics, leading the convergence of clinical laboratories, life sciences and intellectual property through the development of unique diagnostic platform technologies that offer numerous advantages over previous standards. As a global company, Enzo Biochem employs cross-functional teams to develop and deploy products, systems and services that meet the ever-changing and rapidly evolving needs of healthcare today and into the future. Behind Enzo Biochem’s products and technologies is a broad and deep intellectual…
Read on GNW: Enzo Biochem, Inc. Announces Date of Annual Stockholders’ Meeting
